Topical Therapy for Drug-Resistant Pyoderma in Small Animals

Veterinary Clinics of North America - Small Animal Practice

Volumn 43, Issue 1, 2013, Pages 41-50

  Jeffers, James G ^a  

^a Animal Dermatology and Behavior Clinics Inc   (United States)

Author keywords

Barrier; Benzoyl; Chlorhexidine; Hypochlorous; Liposomes; Methicillin resistant; Mupirocin; Nisin

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; BENZOYL PEROXIDE; CHLORHEXIDINE; FUSIDIC ACID; HYPOCHLORITE SODIUM; HYPOCHLOROUS ACID; LACTIC ACID ETHYL ESTER; LANTIBIOTIC; PSEUDOMONIC ACID; SHAMPOO;

ANTIBIOTIC RESISTANCE; DRUG EFFICACY; INFECTION PREVENTION; LACTOCOCCUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS FLUORESCENS; PYODERMA; REVIEW; SHORT COURSE THERAPY; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS; TOPICAL TREATMENT;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; CAT DISEASES; CATS; DOG DISEASES; DOGS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PYODERMA; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS;

ANIMALIA; STAPHYLOCOCCUS;

EID: 84870187727     PISSN: 01955616     EISSN: 18781306     Source Type: Journal    
DOI: 10.1016/j.cvsm.2012.09.006     Document Type: Review

References (34)

1. Beck K.M., Waisglass S.E., Dick H.L., et al. Prevalence of methicillin-resistant Staphylococcus pseudintermedius (MRSP) from skin and carriage sites of dogs after treatment of their meticillin-resistant or meticillin-sensitive staphylococcal pyoderma. Vet Dermatol 2012, 23(4). 369-e67.
2. Kwochka K.W., Kowalski J.J. Prophylactic efficacy of four antibacterial shampoos against Staphylococcus intermedius in dogs. Am J Vet Res 1991, 52:115-118.
3. Nagata M., Murayama N., Shibata K. Efficacy of Nolvasan surgical scrub containing 2 chlorhexidine acetate in topical management of canine superficial pyoderma a randomized double-blinded controlled study. Jpn J Vet Dermatol 2006, 12:1-6.
4. Ascher F., Maynard L., Laurent J., et al. Controlled trial of ethyl lactate and benzoyl peroxide shampoos in the management of canine surface pyoderma and superficial pyoderma. Advances in veterinary dermatology 1990, 375. Balliere Tindall, London. C. Von Tscharner, R.E. Halliwell (Eds.).
5. Murayama N., Nagata M., Terada Y., et al. Efficacy of a surgical scrub including 2% chlorhexidine acetate for canine superficial pyoderma. Vet Dermatol 2010, 21:586-592.
6. Loeffler A., Cobb M.A., Bond R. Comparison of a chlorhexidine and a benzoyl peroxide shampoo as sole treatment in canine superficial pyodermas. Vet Rec 2011, 169:249.
7. Scott D.W., Miller W.H., Cayette S.M. A clinical study on the effect of two commercial veterinary benzoyl peroxide shampoos in dogs. Canine Practice 1994, 19:7-10.
8. Murayama N., Nagata M., Terada Y., et al. Comparison of two formulations of chlorhexidine for treating canine superficial pyoderma. Vet Rec 2010, 167:532-533.
9. Young R., Buckley L., McEwan N., et al. Comparative in vitro efficacy of antimicrobial shampoos: a pilot study. Vet Dermatol 2012, 23:36-40.
10. Guaguere E. Topical treatment of canine and feline pyoderma. Vet Dermatol 1996, 7:145-151.
11. Prottey C., George D., Leech R.W., et al. The mode of action of ethyl lactate as a treatment for acne. Br J Dermatol 1984, 110:475-485.
12. Abbott WH, Lemons CL, Gram WD. In vitro activity of chlorhexidine gluconate against Staphylococcus intermedius. In: Proceedings of the AAVD/ACVD 14th meeting. San Antonio (TX); 1998. p. 17.
13. Murayama N., Terada Y., Okuaki M., et al. Dose assessment of 2% chlorhexidine acetate for canine superficial pyoderma. Vet Dermatol 2011, 22:449-453.
14. Scott D.W., Miller W.H., Griffin C.E. Muller and Kirk's small animal dermatology 2001, WB Saunders, Philadelphia, p. 221-4. 6th edition.
15. Werner A.H., Russell A.D. Mupirocin, fusidic acid and bacitracin: activity, action and clinical uses of three topical antibiotics. Vet Dermatol 1999, 10:225-240.
16. White S.D., Bordeau P.B., Blumstein P., et al. Feline acne and results of treatment with mupirocin in an open clinical trial: 25 cases (1994-96). Vet Dermatol 1997, 8:157-164.
17. Dowling P.M. Antimicrobial therapy of skin and ear infections. Can Vet J 1996, 37:695-699.
18. Burrows AK. Residual antimicrobial action of 2% mupirocin ointment. In: Proceedings of the AAVD/ACVD 10th meeting. Charleston (SC); 1994. p. 35.
19. Kaplan S. Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients. Infect Dis Clin North Am 2005, 19:747-757.
20. Winter J., Ilbert M., Graf P.C., et al. Bleach activates a redox-regulated chaperone by oxidative protein unfolding. Cell 2008, 135:691-701.
21. Fisher R.G., Chain R.L., Hair P.S., et al. Hypochlorite killing of community- acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2008, 27:934-935.
22. Oculus Innovative Sciences, Inc. Vetericyn: one-step wound and infection care and animal wellness products. Available at: Accessed May 31, 2012. http://vetericyn.com/veterinarians/.
23. Brötzaand H., Sahl H.G. New insights into the mechanism of action of lantibiotics-diverse biological effects by binding to the same molecular target. J Antimicrob Chemother 2000, 46:1-6.
24. Frank LA, Kirzeder EM, Davis JA, et al. Nisin impregnated wipes for the treatment of canine pyoderma and surface bacterial colonization. In: Proceedings of the North American Veterinary Dermatology 24th Forum. Savannah (GA); 2009. p. 215.
25. Hasper H.E., Kramer N.E., Smith J.L., et al. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science 2006, 313:1636-1637.
26. Ruhr E., Sahl H.G. Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrobial Agents Chemother 1985, 27:841-845.
27. Delves-Broughton J., Blackburn P., Evans R.J., et al. Applications of the bacteriocin, nisin. Antonie Van Leeuwenhoek 1996, 69:193-202.
28. Dutta P.K., Dutta J., Tripathi V.S. Chitin and chitosan: chemistry, properties and applications. J Sci Ind Res 2004, 63:20-31.
29. Singh A., Malviya R., Sharma P.K. Novasome-a breakthrough in pharmaceutical technology a review article. Adv Biol Res 2011, 5:184-189.
30. Quelch V. Exploring microvesicle technology: tiny structures lead to advances in dermatology therapy. Veterinary Product News May/June 1996, 26-27.
31. Barthe N., Jasmin P., Brouillaud B., et al. Assessment of the distribution of radiolabelled non-ionic multilamellar surfactant microvesicles following topical application to canine skin biopsies: a preliminary study. J Drug Deliv Sci Technol 2005, 15:183-185.
32. Piekutowska A., Pin D., Rème C.A., et al. Effects of a topically applied preparation of epidermal lipids on the stratum corneum barrier of atopic dogs. J Comp Pathol 2008, 138:197-203.
33. Coderch L., López O., Maza A., et al. Ceramides and skin function. Am J Clin Dermatol 2003, 4:107-129.
34. Reiter L.V., Torres S.M., Wertz P.W. Characterization and quantification of ceramides in the nonlesional skin of canine patients with atopic dermatitis compared with controls. Vet Dermatol 2009, 20:260-266.